Effects of aging and liver disease on disposition of lorazepam

Clin Pharmacol Ther. 1978 Oct;24(4):411-9. doi: 10.1002/cpt1978244411.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Adult
  • Aging*
  • Anti-Anxiety Agents / metabolism*
  • Female
  • Hepatitis, Viral, Human / metabolism
  • Humans
  • Kinetics
  • Liver Cirrhosis, Alcoholic / metabolism
  • Liver Diseases / metabolism*
  • Lorazepam / metabolism*
  • Male
  • Middle Aged

Substances

  • Anti-Anxiety Agents
  • Lorazepam